Clofazimine is an antibiotic that is used to treat leprosy. It works by reducing the growth of bacteria that cause leprosy. It is also known as Lamprene. Clofazimine is usually taken by mouth in capsule or tablet form. It is usually taken once or twice daily with meals. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
Clofazimine is a rimininophenazine antimycobacterial medication primarily used to treat leprosy, also known as Hansen's disease. Here's a detailed description of its properties:
Function:
- While the exact mechanism of action against Mycobacterium leprae, the bacteria causing leprosy, is not fully understood, it is believed to work through various pathways:
- Intercalating with bacterial DNA: This disrupts the bacteria's ability to replicate.
- Increasing cellular phospholipase A2 levels: This may contribute to anti-inflammatory effects.
Applications:
- Primarily used in combination therapy for the treatment of various forms of leprosy, including:
- Lepromatous leprosy: A more severe and contagious form with widespread skin lesions, numbness, and muscle weakness.
- Dapsone-resistant lepromatous leprosy: Cases where the bacteria have developed resistance to another leprosy medication, dapsone.
- Lepromatous leprosy complicated by erythema nodosum leprosum: This involves red, tender nodules and thickened skin patches.
Dosage and Administration:
- Typically administered as capsules taken by mouth with food or milk to enhance absorption.
- The exact dosage and duration of treatment are determined by a doctor based on the specific type and severity of leprosy, as well as individual factors. Treatment can be lengthy, lasting up to 2-3 years in some cases.
Important Notes:
- Clofazimine should always be used in combination with other anti-leprosy medications to prevent the development of drug resistance.
- Common side effects can include:
- Skin discoloration (turning reddish-brown or black)
- Dryness and itching of the skin
- Gastrointestinal issues like nausea, vomiting, and diarrhea
- Dizziness and fatigue
- Not recommended for pregnant or breastfeeding women due to potential risks to the developing baby.
- May interact with certain other medications, so it's crucial to inform your doctor about all medications you are taking before starting Clofazimine.
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J04 Antimycobacterials
J04B - Drugs for treatment of lepra
J04BA Drugs for treatment of lepra
ATC Code
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J04 Antimycobacterials
J04B - Drugs for treatment of lepra
J04BA Drugs for treatment of lepra
ATC Code
External Links
Clofazimine